About PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation is a rare disease catalogued by Orphanet (ORPHA:438216). It is associated with the PURA gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation trials.
Search ClinicalTrials.gov for "PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation" or filter by Orphanet code ORPHA:438216 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation. Updated daily.